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Abstract
Background: Reducing readmission is a key quality improvement target for policymakers. The purpose
of the present study was to define incidence and identify factors associated with readmission after a
hepatic resection.
Methods: Thirty-day readmission after discharge and factors associated with a higher risk of readmis-
sion were examined among patients undergoing a hepatic resection at Johns Hopkins Hospital between
2008 and 2012.
Results: Among the 338 patients, the median age was 57.9 years and 173 (51.2%) were men. Indica-
tions for surgery included colorectal cancer liver metastasis (38.2%), primary hepatic tumours (25.7%)
and benign disease (3.3%). Surgical resection consisted of less than a hemi-hepatectomy in the majority
of patients (n = 224, 66.3%). The median index hospitalization length-of-stay (LOS) was 5 days; 68.7%
patients experienced at least one inpatient complication. Overall 30-day readmission was 14.2% (n = 48).
The majority of readmitted patients (n = 46, 95.8%) had a complication prior to readmission. The median
LOS for readmission was 4 [interquartile range (IQR) 2–6] days. On multivariable analysis, the strongest
independent predictor of readmission was the presence of a major complication [odds ratio (OR) 5.30,
95% confidence interval (CI) 2.38–11.78, P < 0.001].
Conclusions: Readmission after a hepatic resection occurs in approximately one out of every seven
patients. Patients who experience a post-operative complication are greater than five times more likely to
be readmitted. Prospective studies are needed to evaluate methods to reduce unplanned readmissions.
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Introduction
Readmission after hospitalization is a relatively common occur-
rence and has a substantial negative impact on the United States
healthcare system.1 In fact, an estimated 2.5 million Medicare
beneficiaries and nearly 2 million others experienced an
unplanned readmission within 30 days of hospital discharge in
2010.1 The monetary effect from these readmissions alone
resulted in an estimated cost of $44 billion.1 Because of this,
several efforts have been aimed at reducing these potentially
preventable occurrences.2 In fact, the Center for Medicare and
Medicaid Services (CMS) has emphasized the reduction of such
unplanned readmissions and assesses a 3% penalty against a
hospital’s overall reimbursement for excess readmissions for a
variety of causes. Furthermore, in addition to the economic
drawback, readmissions have been tied to worse prognosis and
have even been shown to have a detrimental effect on long-term
survival.3–6
Several studies have examined rates and patterns of readmis-
sion in various surgical specialties in order to identify factors that
can be targeted to reduce readmission rates. Previous reports have
focused on surgical patients after colorectal,5 pancreatic4 and
mixed hepatobiliary6 operations. The present authors previously
reported a 30-day readmission rate of 16.4% among patients
undergoing a major resection for hepatic, biliary and pancreatic
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malignancies using the Surveillance Epidemiology and End
Results (SEER)-Medicare database.6 The incidence of readmission
after hepatopancreatobiliary resections remained stable between
1986 and 2005 and that patients with an Elixhauser7 comorbi-
dity score >13, prolonged index hospitalization, or those who
suffered a post-operative complication were at a higher risk for
readmission.
Although patient-related factors account for the overwhelming
majority of variation in readmission, other factors including phy-
sician and hospital-related factors are undoubtedly involved.4
Barbas et al.8 previously examined readmission in patients after a
hepatic resection and reported that a major hepatectomy, major
post-operative complications and an index hospitalization > 7
days were strongly associated with a higher risk of readmission.
The aim of the present study was to validate these findings and
define the incidence of 30-day readmission after a hepatic resec-
tion at a tertiary hepato-pancreatico-biliary (HPB) specialized
academic centre. In addition, the objective was to identify patterns
of readmission as well as risk factors associated with a higher risk
of readmission in patients after a hepatic resection.
Patients and methods
Study population and data collection
All patients who underwent a hepatic resection for benign or
malignant disease at the Johns Hopkins Hospital between 2008
and 2012 were identified. Patients with incomplete data on hos-
pital course and post-discharge status were excluded from analysis
(n = 20). Standard patient demographic and clinicopathological
characteristics were collected including age, gender, race, Ameri-
can Society of Anesthesiologist (ASA) class, as well as Eastern
Cooperative Oncology Group (ECOG) performance status, pres-
ence of comorbidities or significant pre-operative weight loss (>10
pounds), model for end-stage liver disease (MELD) score, admis-
sion type (emergent, urgent and elective) and indication for a
hepatectomy. Operative data including type and extent of hepatic
resection, concomitant non-hepatic procedures, estimated blood
loss (EBL), operative time and transfusion requirements were
recorded. A major hepatectomy was defined as the removal of ≥3
Couinaud segments, whereas a minor hepatectomy consisted of
the removal of < 3 Couinaud segments. Post-operative data
included intensive care unit (ICU) length-of-stay (LOS), overall
hospital LOS, need for reoperation and discharge destination.
Peri-operative morbidity was defined based on the Clavien–
Dindo classification system: grade 1 and 2 were considered as
minor complications whereas grade 3 and 4 were considered as
major complications.9 Mortality was calculated from the date of
the index operation. Readmission indications and rates were
recorded within 30 days from discharge of the index hospitaliza-
tion. In general, all patients are seen in follow-up 2–4 weeks after
the operation and then every 3–6 months, as dictated by the
disease process. Death was ascertained through hospital records
and/or the social security death index.
Statistical analysis
Median values with interquartile ranges (IQRs) were used to
describe continuous data whereas totals and frequencies are used
for discrete variables. Univariate comparisons were assessed using
analysis of variance, the Kruskal–Wallis test, or the chi-square test
as appropriate. Univariate and multivariate logistic regression
models were constructed to explore the association of covariates
with readmission. Variables with a univariate significance <0.20
were entered into the multivariate model along with any clinically
significant variables and potential confounders. All reported
P-values were two-tailed and a P-value < 0.05 was considered
statistically significant. Survival was calculated using the Kaplan–
Meier method and median survivals were compared using the
log-rank test. Overall survival time was calculated from the date of
the index procedure to the date of death. All statistical analyses
were performed using STATA 12.0 (StataCorp, College Station,
TX, USA).
Results
Patients and operative details
338 patients between 2008 and 2012 who underwent hepatic
resection at Johns Hopkins Hospital were identified and met the
inclusion criteria (Table 1). The median pre-operative MELD
score was 6.4 (IQR: 6.4, 7.5) with 9.4% (n = 30) of patients having
a MELD score ≥10. A small subset of patients had evidence of
pre-operative cirrhosis (n = 8, 2.3%) or ascites (n = 5, 1.5%)
whereas the overwhelming majority of patients had normal pre-
operative bilirubin levels (mean: 1.2 mg/dl). The indication for
surgery was for a malignant disease in the majority of patients
(n = 327, 96.7%); only a small subset underwent surgery for a
benign indication (n = 11, 3.3%). Surgical resection consisted of
either a minor (n = 224, 66.3%) or a major (n = 114, 33.7%)
hepatectomy with a median of two segments resected (IQR: 0, 4).
A majority of patients (n = 190, 56.2%) underwent an additional
concomitant non-hepatic procedure, often involving a partial dia-
phragmatic resection (n = 31, 16.3%) or extrahepatic biliary tract
resection (n = 26, 13.7%). Themedian operative time was 291 min
(IQR: 191, 399) with a median estimated blood loss of 500 ml
(IQR: 200, 850). Post-operative complications were common
(n = 230, 68.7%), however the majority of complications were
minor (n = 153, 66.5%) (Table 1).
The median ICU LOS was 1 day (IQR: 1, 2) and the median
overall hospital LOS was 5 days (IQR: 4, 8). At the time of dis-
charge from the index hospitalization, 96.7% of patients were
discharged to home with a small subset of patients (n = 11, 3.3%)
discharged to a skilled nursing or other inpatient facility. The
peri-operative 90-day mortality rate was 3.0% (n = 10).
Readmission analyses
The all-cause readmission rate within 30-days from index hospi-
talization discharge was 14.2% (n = 48). Stratified by procedure
type, 13.8% of patients who underwent less than a hemi-
hepatectomy were readmitted whereas 15.0% of patients who
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Table 1 Clinicopathological, operative and post-operative characteristics stratified by 30-day readmission status
All (n = 338) No readmission (n = 290) Readmission (n = 48) P-value
Age, years, median (IQR) 57.9 (50.5, 68.0) 57.6 (50.9, 67.9) 60.5 (50.0, 70.1) 0.68
Male gender 173 (51.2) 149 (51.4) 24 (50.0) 0.86
Caucasian race 267 (79.0) 226 (78.0) 41 (85.4) 0.67
BMI, median (IQR) 26.5 (23.0, 30.2) 26.6 (23.2, 30.2) 25.4 (22.5, 31.4) 0.42
ASA 0.31
1 & 2 99 (29.3) 82 (28.3) 17 (35.4)
3 & 4 239 (70.7) 208 (71.7) 31 (64.6)
ECOG performance status 0.42
0 260 (76.9) 225 (77.6) 35 (72.9)
1 74 (21.9) 62 (21.4) 12 (25.0)
2–3 4 (1.2) 3 (1.0) 1 (2.1)
Recent weight loss > 10lb 74 (21.9) 56 (19.3) 18 (37.5) 0.002
Pre-operative MELD Score 0.10
< 10 288 (90.6) 252 (91.6) 36 (83.7)
≥ 10 30 (9.4) 23 (8.4) 7 (16.3)
Admission type 0.78
Elective 334 (99.1) 286 (99.0) 48 (100)
Urgent 1 (0.3) 1 (0.3) 0
Emergent 2 (0.6) 2 (0.7) 0
Diagnosis 0.98
Benign tumour 11 (3.3) 9 (3.1) 2 (4.2)
Primary liver malignancy 87 (25.7) 75 (25.9) 12 (25.0)
Colorectal metastasis 129 (38.2) 111 (38.3) 18 (37.5)
Other metastasis 111 (32.8) 95 (32.8) 16 (33.3)
Liver resection type 0.59
<Hemi-hepatectomy 224 (66.3) 193 (66.6) 31 (64.6)
Hemi-hepatectomy 66 (19.5) 58 (20.0) 8 (16.7)
Extended hepatectomy 48 (14.2) 39 (13.4) 9 (18.7)
Resected segments, median (IQR) 2 (0–4) 2 (0–4) 1 (0–4) 0.87
Concurrent resection 190 (56.2) 159 (54.8) 31 (64.6) 0.21
Operative time, median (IQR) 291 (191–399) 286 (194–389) 340 (165–471) 0.71
EBL, ml, median (IQR) 500 (200–850) 500 (200–900) 500 (200–800) 0.73
ICU LOS, days, median (IQR) 1 (1–2) 1 (1–2) 2 (1–3) 0.01
Total LOS, days, median (IQR) 5 (4–8) 5 (4–8) 6 (5–12) 0.01
Complications during index hospitalization (n = 335) <0.001
No complications 105 (31.3) 103 (35.9) 2 (4.2)
Grade 1 & 2 153 (45.7) 136 (47.4) 17 (35.4)
Grade 3 & 4 70 (20.9) 41 (14.3) 29 (60.4)
Death 7 (2.1) 7 (2.4) 0
Discharge destination 0.21
Home 320 (96.7) 276 (97.2) 44 (93.6)
Other 11 (3.3) 8 (2.8) 3 (6.4)
Reoperation 16 (4.7) 12 (4.1) 4 (8.3) 0.21
Mortality within 90 days 10 (3.0) 10 (3.5) 0 0.19
IQR, interquartile range; BMI, body mass index; ASA, American Society of Anesthesiologists; ECOG, Eastern Cooperative Oncology Group; MELD,
model for end-stage liver disease; EBL, estimated blood loss; ICU, intensive care unit; LOS, length of stay.
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underwent a greater than hemi-hepatectomy were readmitted (P =
0.52). The median time to readmission was 7 days (IQR: 5, 16).
Among those patients readmitted, early readmission was common
as 52.1% (n = 25 out of 48 patients who were readmitted) patients
were readmitted within 1 week of discharge (Fig. 1). The majority
of readmissions were for gastrointestinal or infectious reasons,
including an intra-abdominal abscess (n = 11, 22.9%) and
cholangitis (n = 6, 12.6%) (Fig. 2).Among the patients readmitted,
the median LOS for the second hospitalization was 4 (IQR 2–6)
days. Of note, four patients (8.3%) required a second operation
owing to a peri-operative complication whereas three patients
(6.3%) experienced an in-hospital mortality after readmission.
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Figure 1 Distribution of time to readmission after a hepatectomy
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Figure 2 Common indications for readmission after a hepatectomy
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Several clinical factors were associated with an increased risk of
readmission after a hepatic resection (Table 2).While patient male
gender [odds ratio (OR) 0.95, 95% confidence interval (CI) 0.51–
1.74], older age (OR 1.50, 95% CI 0.81–2.78) and the presence of
multiple medical comorbidities (OR 0.80, 95%CI 0.43–1.48) were
not associated with an increased risk of readmission (all P > 0.05),
other patient-specific factors including pre-operative weight loss
> 10 lb (OR 2.84, 95% CI 1.46–5.55) were associated with a higher
likelihood of readmission (P < 0.05). Interestingly, no pathological
or operative factors were associated with an increased risk of
readmission. In particular, an operative time greater than median
(OR 1.34, 95% CI 0.72–2.48) and EBL greater than median
(OR 1.03, 95% CI 0.53–2.02) did not impact a patient’s likelihood
of readmission (both P > 0.05). In contrast, a number of post-
operative factors were associated with an increased risk of read-
mission. These post-operative factors included an ICU LOS ≥2
days (OR 2.85, 95% CI 1.52–5.36), as well as an overall LOS ≥5
days (OR 3.19, 95% CI 1.44–7.07) during the index admission
(both P < 0.05). Patients experiencing a major complication
during the index hospitalization were also at a much higher risk
for readmission (Clavien–Dindo grade 3 and 4: OR 5.66, 95% CI
2.83–11.32; P < 0.001). In fact, the majority of readmitted patients
(n = 46, 95.8%) had had a peri-operative complication prior to
readmission. After adjusted analysis, the presence of a major
Table 2 Logistic regression analysis of factors associated with 30-day readmission
Variables Univariate analysis Multivariate analysis
OR 95% CI P-value OR 95% CI P-value
Age ≥ 58 1.50 0.81–2.78 0.20 1.23 0.57–2.66 0.60
Male gender 0.95 0.51–1.74 0.86 – – –
Caucasian race 1.63 0.70–3.82 0.26 – – –
BMI ≥ 30Kg/m2 1.08 0.51–2.28 0.83 – – –
ASA
1 & 2 Ref
3 & 4 0.72 0.38–1.37 0.32 – – –
ECOG
0 Ref
1–3 1.29 0.64–2.57 0.48 – – –
Recent weight loss > 10 lb 2.84 1.46–5.55 0.002 1.88 0.82–4.32 0.14
MELD ≥ 10 2.13 0.85–5.32 0.11 1.28 0.39–4.23 0.68
Diagnosis
Benign tumour Ref
Primary liver malignancy 0.72 0.14–3.74 0.70 – – –
Colorectal metastasis 0.73 0.15–3.65 0.70 – – –
Other metastasis 0.76 0.15–3.83 0.74 – – –
Major hepatectomy 1.46 0.78–2.70 0.24 1.47 0.64–3.37 0.36
Concurrent resection 1.41 0.60–3.30 0.43 – – –
Prolonged operative time 1.34 0.72–2.48 0.35 – – –
ICU LOS ≥ 2 days 2.85 1.52–5.36 0.001 1.08 0.48–2.45 0.85
LOS ≥ 5 days 3.19 1.44–7.07 0.004 1.05 0.36–3.05 0.83
EBL ≥ 500 ml 1.03 0.53–2.02 0.93
Complication within 30 days
Grade 1 & 2 Ref Ref
Grade 3 & 4 5.66 2.83–11.32 <0.001 5.30 2.38–11.78 <0.001
Discharge destination
Home Ref
Facilities 2.35 0.60–9.21 0.22 – – –
Need for reoperation 2.11 0.65–6.82 0.21 – – –
BMI, body mass index; ASA, American Society of Anesthesiologists; ECOG, Eastern Cooperative Oncology Group; MELD, model for end-stage liver
disease; EBL, estimated blood loss; ICU, intensive care unit; LOS, length of stay.
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complication during the index admission (OR 5.30, 95% CI 2.38–
11.78; P < 0.001) remained independently associated with a higher
risk of readmission.
Discussion
Unplanned readmission after hospitalization is common and
affects patients across all medical and surgical specialties. Read-
mission rates are important as they may serve as an underlying
surrogate marker for provider and/or hospital care.10 As such, it is
important to identify common causes, patterns and factors asso-
ciated with readmission in order to improve the quality of patient
care. Furthermore, other studies have shown that readmission
may negatively impact short- and long-term survival as well as
patient reported quality of life.3–6,11 Patients undergoing complex
surgical procedures are at particular risk for readmission. As such,
previous studies have examined readmission rates, patterns
and influencing factors in patients after colorectal,5 mixed
hepatobiliary6 and pancreas4 resections. The present study is
important as it focused on identifying the incidence of and factors
associated with readmission in patients undergoing hepatic resec-
tions. Previously a readmission rate of 16.4% in patients under-
going mixed hepatopancreatobiliary resections was reported
using population-based national data.6 In the present study, there
was a comparable 30-day all cause readmission rate of 14.2%
among patients undergoing a hepatic resection at a major tertiary
HPB institution. Perhaps more importantly, several patient and
peri-operative factors were identified that were associated with a
greater risk of readmission. In particular, patients who suffered
a major complication during the index hospitalization were at a
five-fold increased risk for readmission.
Analysing factors that are associated with readmission is crucial
as it may help guide management in these high-risk patients, as
well as potentially identify areas to target to decrease readmission.
Surprisingly a major hepatectomy was not associated with a
higher readmission rate, differently than previously reported by
Barbas et al.8 While the reason for this is probably multi-factorial,
it may be as a result of the fact that more and more hepatic
resections are ‘parenchymal sparing’ in nature (e.g. not ‘formal’
hemi-hepatectomies), yet still can be technically challenging in
nature and, on occasion, lead to more blood loss because of being
non-anatomic dissections. A variety of factors including increas-
ing index hospitalization LOS and the presence of post-operative
complications have previously been reported to be associated with
increased readmission after a number of different surgical pro-
cedures.5,6,12,13 Given that these previous studies included patients
undergoing a variety of surgical operations, the data may not be
generalizable to patients undergoing a hepatectomy. In one recent
study examining readmission in patients after a hepatectomy,
Barbas et al. observed a 90-day readmission rate of 14.4% that was
nearly identical to the incidence of readmission reported in the
present study for a similar cohort of patients.8 In the study by
Barbas et al., the authors found that patients who experienced a
major complication and who had an index hospitalization > 7
days were at highest risk for readmission.8 While the present study
similarly showed that patients who experienced a major post-
operative complication during the index hospitalization were at a
much higher risk of readmission (Clavien–Dindo grade 3 and 4:
OR 5.66, 95% CI 2.83–11.32; P < 0.001), it failed to find an
independent association between readmission risk and ICU or
total hospital LOS as previously reported by several other
groups.5,6,12–14 The reason for these disparate results may be related
to differences in LOS among the varied cohorts, as well as
differences in the incidence of morbidity after a hepatectomy that
can often impact both LOS and readmission. Notwithstanding
these differences, it appears clear that early discharge of appropri-
ate patients is safe and does not necessarily lead to increased
readmission. In fact, several groups have recently advocated fast-
track or enhanced recovery programmes after a liver resection and
have noted that it was safe and effective, as well as did not result in
higher rates of readmission.15
There are several limitations that need to be considered when
interpreting the data. First, as with all retrospective studies of this
nature, selection bias was possible. If a patient had been selected
differently (e.g. older, sicker patients), the incidence of readmis-
sion may have been higher. Given that the data were based on the
experience of one specialized HPB centre, the data may not be
generalizable to other institutions or patient populations. It is
reassuring, however, that the data noted herein independently
confirmed a comparable incidence of readmission among HPB
patients previously reported by Barbas et al.8 Lastly, the data are
limited to patients who were readmitted only to Johns Hopkins
Hospital. While it is possible that patients sought care and were
readmitted at other institutions, it is relatively unlikely as most
patients remain in the local area for 1–2 weeks after surgery.While
the number of patients readmitted to outside hospitals is likely
minimal, such a detection bias would have – if anything – resulted
in an underestimation of the incidence of readmission.
In conclusion, readmission after a hepatic resection is common
and occurs in approximately one out of every seven patients.
Patients who experience a post-operative complication are over
five times more likely to be readmitted. Further prospective
studies are needed to evaluate potential methods to reduce these
unplanned readmissions.
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